Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Academic research laboratories running controlled studies need consistent supply from a single batch to minimize variability across experimental conditions
contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Risk of diabetic retinopathy complications in patients with pre-existing retinopathy Potential for acute kidney injury, particularly related to dehydration Caution or avoidance in severe gastroparesis or severe gastrointestinal disease Suicidality warning for weight-management indications (Wegovy, Saxenda) Potential for altered absorption of oral medications due to delayed gastric emptying In older adults with cognitive impairment, medication adherence may be challenging, and gastrointestinal side effects could lead to dehydration or nutritional deficiencies
Any GHK-Cu offered by PureTestedPeptides is for laboratory research only and not for human consumption
Do not use any Semaglutide that appears cloudy or discolored
To date, reducing cardiovascular and renal risk in this population was based on strict control of cardiovascular risk factors and the renin-angiotensin system blockade
Specifically: Adults with a BMI of 30 or above (classified as obese) Adults with a BMI of 27 or above (overweight) who also have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, high cholesterol, or cardiovascular disease These are the same eligibility criteria as the Wegovy injection
